{"id":"https://openalex.org/W2000839039","doi":"https://doi.org/10.1124/mol.61.4.861","title":"Tracazolate Reveals a Novel Type of Allosteric Interaction with Recombinant \u03b3-Aminobutyric AcidA Receptors","display_name":"Tracazolate Reveals a Novel Type of Allosteric Interaction with Recombinant \u03b3-Aminobutyric AcidA Receptors","publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W2000839039","doi":"https://doi.org/10.1124/mol.61.4.861","mag":"2000839039","pmid":"https://pubmed.ncbi.nlm.nih.gov/11901225"},"language":"en","primary_location":{"id":"doi:10.1124/mol.61.4.861","doi":"https://doi.org/10.1124/mol.61.4.861","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mol.61.4.861","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109227522","display_name":"Sally Anne Thompson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sally-Anne Thompson","raw_affiliation_strings":["Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom. sallyanne_thompson@merck.com","1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom. sallyanne_thompson@merck.com","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027172698","display_name":"Peter B. Wingrove","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter B. Wingrove","raw_affiliation_strings":["1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.); and\n2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.); and\n2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012678680","display_name":"Linda Connelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Linda Connelly","raw_affiliation_strings":["1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.); and\n2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.); and\n2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055408422","display_name":"Paul John Whiting","orcid":"https://orcid.org/0000-0002-4121-1379","observed_orcids":["https://orcid.org/0000-0002-4121-1379"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul J. Whiting","raw_affiliation_strings":["1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.); and\n2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.); and\n2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072439028","display_name":"Keith A. Wafford","orcid":"https://orcid.org/0000-0002-8508-4738","observed_orcids":["https://orcid.org/0000-0002-8508-4738","https://orcid.org/0000-0003-4537-4690"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Keith A. Wafford","raw_affiliation_strings":["1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.); and\n2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.); and\n2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"1Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Essex, United Kingdom (S.-A.T., P.B.W., P.J.W., K.A.W.)","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"2Wolfson Institute for Biomedical Research, University College London, London, United Kingdom (L.C.)","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":1.513,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.79521838,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"61","issue":"4","first_page":"861","last_page":"869"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.9210000038146973},{"id":"https://openalex.org/keywords/allosteric-modulation","display_name":"allosteric modulation","score":0.9300000071525574},{"id":"https://openalex.org/keywords/gamma2-subunit","display_name":"gamma2 subunit","score":0.6460000276565552},{"id":"https://openalex.org/keywords/epsilon-subunit","display_name":"epsilon subunit","score":0.8309999704360962},{"id":"https://openalex.org/keywords/beta3-subunit","display_name":"beta3 subunit","score":0.7739999890327454},{"id":"https://openalex.org/keywords/receptor-chimeras","display_name":"receptor chimeras","score":0.6230000257492065},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.6510000228881836},{"id":"https://openalex.org/keywords/gaba-potentiation","display_name":"GABA potentiation","score":0.6370000243186951},{"id":"https://openalex.org/keywords/intrinsic-efficacy","display_name":"intrinsic efficacy","score":0.6890000104904175},{"id":"https://openalex.org/keywords/pyrazolopyridines","display_name":"pyrazolopyridines","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.717797040939331},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.6155372858047485},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.5911021828651428},{"id":"https://openalex.org/C25274449","wikidata":"https://www.wikidata.org/wiki/Q1805481","display_name":"Long-term potentiation","level":3,"score":0.5871940851211548},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.4786842465400696},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.44298145174980164},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41658318042755127},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39745938777923584},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3889976441860199},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36441171169281006},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001216","descriptor_name":"Asparagine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002712","descriptor_name":"Chlorides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1124/mol.61.4.861","doi":"https://doi.org/10.1124/mol.61.4.861","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mol.61.4.861","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},{"id":"pmid:11901225","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11901225","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.46810001134872437,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W165635918","https://openalex.org/W1606994795","https://openalex.org/W1748513738","https://openalex.org/W1837153647","https://openalex.org/W1915045256","https://openalex.org/W1950992052","https://openalex.org/W1964568422","https://openalex.org/W1965876699","https://openalex.org/W1969428348","https://openalex.org/W1970739803","https://openalex.org/W1972901946","https://openalex.org/W1974022934","https://openalex.org/W1977052342","https://openalex.org/W1987888770","https://openalex.org/W1988139687","https://openalex.org/W1988214857","https://openalex.org/W1993000960","https://openalex.org/W1996480937","https://openalex.org/W1997899750","https://openalex.org/W2002601777","https://openalex.org/W2019608696","https://openalex.org/W2023427309","https://openalex.org/W2035838035","https://openalex.org/W2047243202","https://openalex.org/W2053718517","https://openalex.org/W2053751304","https://openalex.org/W2059401172","https://openalex.org/W2060053228","https://openalex.org/W2061321235","https://openalex.org/W2080245295","https://openalex.org/W2086547360","https://openalex.org/W2091751135","https://openalex.org/W2099883420","https://openalex.org/W2105418849","https://openalex.org/W2106607972","https://openalex.org/W2106915249","https://openalex.org/W2107731277","https://openalex.org/W2110151543","https://openalex.org/W2118922355","https://openalex.org/W2126535828","https://openalex.org/W2134156205","https://openalex.org/W2143411102","https://openalex.org/W2162666247","https://openalex.org/W2163080015","https://openalex.org/W2264231063","https://openalex.org/W2403225636","https://openalex.org/W2410908424","https://openalex.org/W2413732288","https://openalex.org/W2433839752","https://openalex.org/W2437611304","https://openalex.org/W2466985577","https://openalex.org/W2580297957","https://openalex.org/W4244655679","https://openalex.org/W4406059090"],"related_works":["https://openalex.org/W7006310096","https://openalex.org/W1594120948","https://openalex.org/W2066789664","https://openalex.org/W2074422389","https://openalex.org/W2466985577","https://openalex.org/W2396372558","https://openalex.org/W7096969928","https://openalex.org/W2050689012","https://openalex.org/W2416042073","https://openalex.org/W1995130008"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}